Back to Report Store Home

Stem Cell Research - Market Trends, Investment Trends and Pipeline Analysis

  • Published: Jan-2010
  • Report Code: GBIHC009MR
  • Report Format: pdf

Description

GBI Research, the leading business intelligence provider, has released its latest research “Stem Cell Research - Market Trends, Investment Trends and Pipeline Analysis”. It is an essential source of information and analysis on global stem cell research and development. This pharmaceutical and healthcare report identifies the key trends shaping and driving stem cell research and development. The report analyses investment decisions within the stem cell research market by providing information on pipelines, federal spending, investor perspectives, regulatory environment, competitive landscape and market potential. The study also provides insight on the prevalent competitive landscape and the emerging players expected to significantly shift the market positioning. Most importantly, the report provides valuable insight on the pipeline products within the global stem cell industry.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope

  • The scope of this report includes:

  • Unmet needs and opportunity analysis for therapies that are currently in pipeline.

  • Market characterization including market sizing, technology adoption framework and business models for the stem cell market.

  • A cross-country analysis for regulatory framework, investments, research clusters and support including the US (United States), the UK (United Kingdom), Germany, France, Japan, China, India, Singapore, Canada and Australia

  • In-depth information and analysis on the pipeline products expected to bring a shift in the market positions of the leading manufacturers.

  • Analysis and review of the key events and milestones that will impact the future of the global stem cell market. Each trend independently researched to provide qualitative analysis of what the implications on sectors are, and how companies are responding to these trends.

  • Insightful review of key industry drivers, restraints and challenges which are likely to impact the global stem cell research and development in the long run.

  • Information on the leading market players and the prevailing competitive landscape. Key companies covered include Osiris Therapeutics, Aastrom Biosciences, Cytori Therapeutics, Pluristem Therapeutics and Geron.

Reasons To Buy

  • The report will enhance your decision making capability. It will allow you to:

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying companies with the most robust pipelines

  • Develop business strategies by understanding the trends shaping and driving stem cell research and development.

  • Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the stem cell market in the future

  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors

  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships

  • What’s the next big thing in the stem cell research and development landscape – Identify, understand and capitalize.

 
      captcha refresh

I have read and accept terms and conditions and privacy policy

Cancel
License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$3500
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$7000
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$10500
Email to a colleague Request Sample Pages Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5817
Or click here to contact us
Secure Payments
Cards